OR WAIT null SECS
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
A new study just released by the Tufts Center for the Study of Drug Development (CSDD) shows that the proportion of a given race or ethnicity among investigative site personnel closely aligns with the corresponding race and ethnicity of patients enrolled in clinical trials at that site. The study also found that worldwide, regardless of geographic location, the diversity of patients enrolled in clinical trials is highly correlated with site personnel diversity.
The Tufts CSDD analysis is based on an online global survey of 3,462 principal investigators, study coordinators and site administrators. More than half of respondents are based in academic medical centers, large health systems and community hospitals; 43% are based in private physician practices, investigative sites, and site networks.
Key findings from the study are summarized in the November/December Tufts CSDD Impact Report, released today, and include the following: